Navigation Links
New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides
Date:10/5/2009

HOUSTON, Oct. 5 /PRNewswire/ -- PAC, a leading global provider of advanced analytical instruments for laboratories and online process applications, announces the introduction of the ANTEK MultiTek(TM) testing system for the fast, accurate detection of sulfur, nitrogen, and halides. Industries include BioFuels, Chemicals, Food & Beverage, Manufacturing and Assembly, Medical, Pharmaceutical, Environmental, and many more.

"MultiTek(TM) is the only instrument on the market that combines testing for sulfur, nitrogen, and halides all in one," Ron K. Holsey, Vice President, Refining Business Segment, said in making the announcement. "MultiTek is compact, powerful, automated, and multi-configurable; it's the perfect solution to today's increasing demand worldwide for fast, accurate detection and analysis of unwanted chemicals, pollutants, contaminants, and corrosive elements." Because MultiTek(TM) delivers precise results with high sensitivity and unmatched versatility, Holsey added, "It's a valuable process optimization tool that will deliver faster ROI and a better bottom line."

MultiTek(TM) detects sulfur, nitrogen, and halides through a uniquely efficient process that includes combustion Ion Chromatography (IC), Ultraviolet Fluorescence (UVF), and Chemiluminescence technologies. MultiTek(TM) is superior to wet chemistry and XRF; works with solid, liquid, gas, and LPG samples; and provides lower detection levels than competitive systems.

MultiTek(TM) helps users protect electronics, refinery products, and others against the corrosive effects of halides (Chloride, Fluoride, and Bromide) and Sulfur; protect people, animals, plant and aquatic life from the harmful effects of Halides, Sulfur, and Nitrogen in the environment. MultiTek(TM) also helps users reduce overhead costs, increase productivity, and ensure product compliance across a wide range of industries and applications, from fuels to pharmaceuticals to 'green' manufacturing. MultiTek(TM) is part of PAC's well-established ANTEK product line.

About PAC

PAC is a dominant global provider of advanced analytical instruments for laboratories and online process applications. With a product portfolio of over 200 instruments, PAC serves industries such as refinery, petrochemical, biofuels, environmental, food & beverage and pharmaceutical. To provide its customers with cutting edge technology, PAC leverages significant R&D resources to support its core technologies, including chromatography, elemental analysis, physical properties and software applications. PAC's product portfolio includes AC Analytical Controls, ANTEK, Alcor, PetrosSpec, PSPI, ISL and Walter Herzog. For more information, visit www.paclp.com, or contact the company's headquarters at 8824 Fallbrook Dr., Houston, Texas 77064, Tel. (U.S.) 800.444.TEST, or +281.940.1803.

    Contact:
    Michael L. Martel
    MMC, Inc. for PAC
    401-480-3433

SOURCE PAC


'/>"/>
SOURCE PAC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. BioCryst Provides Update Regarding Peramivir for Influenza
2. New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
3. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
4. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
5. Cyberonics Provides Update on Depression Post-Approval Study
6. Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
7. Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
8. Alfacell Provides Shareholder Update
9. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
10. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
11. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Iowa , Jan. 18, 2017   ... that subsidiary Caretta Therapeutics plans, in the second ... Venodol, a topical roll-on intended to provide relief ... opioid and steroidal analgesics. It was developed under ... to commercialize products derived from snake venom. ...
(Date:1/18/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, announces dosing the first patient ... 2 acne rosacea study. DMT210 is a topical ... in the skin responsible for the inflammation and ... This clinical trial, DMT210-003, is a 12-week, Phase ...
(Date:1/18/2017)... Jan. 17, 2017  With an annual growth ranging from 6% to 10%, ... SEA (Jakarta International Expo, March 22-24, 2017) serves the industry by fostering the ... CPhI SEA 2017? Investment Forum ASEAN -- ... Richer conference content Enhanced business matchmaking program ... ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment ... they have achieved certification to ISO 13485. This certification is another way they are ... date products and services that they need. , The ISO 13485 Certification is a ...
(Date:1/18/2017)... NJ (PRWEB) , ... January 18, 2017 , ... ... care communications company, launched a new website for its Center for Biosimilars, announced ... will include the latest developments in the field of biosimilars through thought leader ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... gum disease to enamel erosion, and those dental problems can increase the risk ... Health, many pregnant women are failing to get the dental care they need. ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress ... dentists to choose the best drug option for each patient. Dentists have several general ... better overall outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted ...
(Date:1/17/2017)... ... , ... For breast cancer clinicians and researchers who were unable to attend ... intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual ... on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO ...
Breaking Medicine News(10 mins):